-+ 0.00%
-+ 0.00%
-+ 0.00%

Immix Biopharma Publishes Corporate Presentation on NXC-201 BCMA CAR-T for Relapsed/Refractory AL Amyloidosis

Reuters·03/05/2026 00:18:54

Please log in to view news